RAD001 (Everolimus) Mechanism of Action: mTOR Inhibition in Tumor Cell Research

RAD001 (Everolimus) MOA:Targeting mTOR/PI3K-AKT-mTOR Pathway for Oncology Research

🎯 check RAD001 (Everolimus) product page

RAD001 (Everolimus) is a potent mTOR inhibitor. It affects PI3K/AKT/mTOR signaling by blocking mTOR, inhibiting tumor growth.

Primary Applications and Mechanism of Action